Overview

Dexpramipexole Renal PK Study

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, single-dose, PK and safety study in subjects with various stages of renal impairment.
Phase:
Phase 1
Details
Lead Sponsor:
Knopp Biosciences
Treatments:
Pramipexole